Subsequent Events (Details) - Subsequent Event - Castle Creek Biosciences, Inc - Purchase and sale agreement $ in Millions |
Feb. 24, 2025
USD ($)
shares
|
|---|---|
| Subsequent Event | |
| Aggregate purchase price, Purchasers | $ 75.0 |
| Aggregate purchase price, Xoma portion | $ 5.0 |
| Number of warrants or rights received | shares | 10,464 |
| X | ||||||||||
- Definition The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights received during the period to purchase shares of counterparty under the agreement. No definition available.
|
| X | ||||||||||
- Definition The cash outflow of all investors, including entity, for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|